Keppra approved from 1 month

Keppra (levetiracetam) has been approved for adjunctive treatment of partial-onset seizures with or without secondary generalisation in children from 1 month of age. It was previously licensed for this indication only in children over 6 months.

The starting dose in children aged 1-6 months is 7mg/kg oral solution twice daily.

View Keppra drug record

Further information: UCB

To sign up for the MIMS monthly news update, register at

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from MIMS

Avoid routinely offering antidepressants for 'less severe' depression, says NICE in draft guidance
Products coming soon - live tracker

Products coming soon - live tracker

EXCLUSIVE TO SUBSCRIBERS Monitor forthcoming UK drug...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Intal asthma inhaler to be discontinued

Intal asthma inhaler to be discontinued

The asthma preventer inhaler Intal (sodium cromoglicate)...